Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

11.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Ligand Binding Sites02:40

Ligand Binding Sites

6.0K
6.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.0K
3.0K
Conserved Binding Sites01:49

Conserved Binding Sites

4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

19.3K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
19.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer.

Molecular therapy. Oncology·2025
Same author

A Fragment-Based Electrophile-First Approach to Target Histidine with Aryl-Fluorosulfates: Application to hMcl-1.

Journal of medicinal chemistry·2025
Same author

Purine nucleotides are competitive inhibitors of apo-GOT1.

bioRxiv : the preprint server for biology·2025
Same author

Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo.

Nature communications·2025
Same author

A fragment-based electrophile-first approach to target histidine with aryl-fluorosulfates: application to hMcl-1.

Research square·2025
Same author

Identification of a selective pyruvate dehydrogenase kinase 1 (PDHK1) chemical probe by virtual screening.

European journal of medicinal chemistry·2025

Related Experiment Video

Updated: May 1, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

1.3K

Covalent Targeting of Histidine Residues: A Ligand-First Approach.

Giulia Alboreggia1, Emma L Atienza1, Kendall Muzzarelli2

  • 1Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, California 92521, United States.

Journal of Medicinal Chemistry
|April 29, 2026
PubMed
Summary

Researchers developed new covalent drugs targeting histidine residues, expanding options beyond cysteine for improved oncology therapeutics. This approach enhances drug properties and broadens covalent drug design applicability.

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

10.9K

Related Experiment Videos

Last Updated: May 1, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

1.3K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

10.9K

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Drug Discovery

Background:

  • Irreversible drugs offer improved pharmacodynamic and pharmacokinetic properties in oncology compared to reversible ligands.
  • Current covalent drugs primarily target cysteine residues, limiting their applicability due to cysteine's rarity in protein binding sites.

Purpose of the Study:

  • To explore histidine residues as alternative covalent modification targets.
  • To assess the efficacy of various electrophiles (acrylamides, chloroacetamides, aryl fluorosulfates) for targeting histidine residues.
  • To develop strategies for designing and characterizing histidine-covalent agents.

Main Methods:

  • Ligand-first, structure-based drug design approach.
  • Utilized model peptides to target Histidine 224 (His224) of human Mcl-1 (hMcl-1).
  • Employed biophysical methods for characterization of covalent agents.

Main Results:

  • Demonstrated that aryl fluorosulfates and chloroacetamides can efficiently target histidine residues covalently.
  • Successfully targeted His224 of hMcl-1 using these electrophiles.
  • Established strategies and biophysical approaches for histidine-covalent agent development.

Conclusions:

  • Histidine residues are viable targets for covalent drug design, expanding beyond cysteine.
  • Aryl fluorosulfates and chloroacetamides are effective electrophiles for histidine covalent modification.
  • This research provides a foundation for developing novel histidine-covalent therapeutics in oncology.